Status:
COMPLETED
Prevention of pneumonIA in Nursing hOme
Lead Sponsor:
University Hospital, Toulouse
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Pneumonia
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Infections in nursing home are associated with high morbidity and mortality. Pulmonary infections are known to be the most problematic. In our INCUR observational study of 773 residents, 20.13% of res...
Detailed Description
The pneumopathies in nursing home are the main cause of hospitalization of residents. Depending on the series, 9 to 50% of residents with pneumonia should be transferred. This reflects the difficultie...
Eligibility Criteria
Inclusion
- Living in a nursing home for at least 30 days at the start of inclusions,
- Having received information concerning the study and having not expressed opposition to participate,
- For which an agreement in principle of the attending physician has been obtained.
Exclusion
- Refusal of the resident (or of his legal representative) or of his treating physician after given information,
- Resident at the end of life (life expectancy evaluated within one month by the coordinating physician),
- Resident whose attending physician is already involved in the PIANO study under a resident of another nursing home.
Key Trial Info
Start Date :
October 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2023
Estimated Enrollment :
3818 Patients enrolled
Trial Details
Trial ID
NCT04121182
Start Date
October 19 2020
End Date
June 5 2023
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059